Universal Detection Technology Announces GSA Contract Award for Bioterrorism Detection and Radiological Detection

* Reuters is not responsible for the content in this press release.

Tue Apr 7, 2009 4:00pm EDT

  LOS ANGELES, CA, Apr 07 (MARKET WIRE) -- 
Universal Detection Technology (www.udetection.com) (OTCBB: UNDT), a
developer of early-warning monitoring technologies to protect people from
bioterrorism and other infectious health threats and provider of
counter-terrorism consulting and training services, announced today that
its products have been approved by the General Services Administration
(GSA) to be included on its Multiple Awards Schedule program to 2013.

    Under this contract, federal, state, and local government agencies that
have access to the GSA Schedule Contract program can contract directly
with UNDT for all of their detection needs. Universal Detection's
products are listed on GSA Schedule GS-07F-0106V for equipment used in
the detection of biological weapons such as anthrax, ricin, botulinum,
and plague as well as Radiation Detection Equipment.

    According to Jacques Tizabi, President of Universal Detection Technology,
"UNDT is planning an aggressive marketing campaign to promote its
counter-bioterrorism initiatives to all relevant government agencies to
ensure that all first responders are properly equipped in the event of a
biological crisis and we are pleased to be working together with The
Winvale Group." The company is also marketing its line of Radiation
Detection Equipment.

    To be an approved supplier under a GSA schedule, the vendor must go
through an arduous application process. Negotiating fair and reasonable
prices for the products or services to be delivered is the most important
aspect of application process. The GSA schedule is one of the most
simplified and widely accepted government contract vehicles available to
procurement officers. GSA schedule is a five-year contract listing the
prices the federal government has agreed to pay for a vendor's commercial
products and services. The contract may be renewed for three five-year
periods resulting in a 20-year contract if all renewals are executed.

    The products available from Universal Detection Technology on the GSA
Schedule include:

    BSM-2000 Airborne Anthrax Detection System

    Anthrax Detection Kits (Handheld)

    Ricin Detection Kits (Handheld)

    Botulinum Detection Kits (Handheld)

    Plague Detection Kits (Handheld)

    Personal Radiation Detector

    Gamma Neutron Detection and Search Instrument

    Some other Security firms working with Winvale include, Northrop Grumman,
ICX, and Rapiscan.

    If you are a government customer and wish to inquire, please contact:

    jtizabi@udetection.com

    For more information please visit our website at www.udetection.com or

    Email us at info@udetection.com.

    About Universal Detection Technology

    Universal Detection Technology is a developer of monitoring technologies,
including bioterrorism detection devices. The Company on its own and with
development partners is positioned to capitalize on opportunities related
to Homeland Security. For example, the Company, in cooperation with NASA,
has developed a bacterial spore detector that detects certain biohazard
substances. The Company is also a reseller of handheld assays used for
detection of five bioterrorism agents, radiation detection systems, and
antimicrobial products. For more information, please visit
www.udetection.com.

    Forward-Looking Statements

    Except for historical information contained herein, the statements in this
news release are forward-looking statements that involve known and unknown
risks and uncertainties, which may cause the Company's actual results,
performance and achievement in the future to differ materially from
forecasted results, performance, and achievement. The Company undertakes
no obligation to publicly release the result of any revisions to these
forward-looking statements that may be made to reflect events or
circumstances after the date hereof, or to reflect the occurrence of
unanticipated events or changes in the Company's plans or expectations.

    

Contact:

Jacques Tizabi
310-248-3655
Email Contact

Copyright 2009, Market Wire, All rights reserved.

-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.